
Avastin and Sutent, two cancer drugs, don't produce longer survival in breast cancers patients, probably simply because encourage a rise in the amount cancer stem cells in breast tumors, based on a report executed on mice by researchers through the Michigan Comprehensive Cancer Center, and published from the Proceedings with the National Academy of Sciences (early edition).
Though Sutent (sunitinib)...